• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他克林与人乙酰胆碱酯酶结合特性的计算研究:对接和电子结构。

In silico study of tacrine and acetylcholine binding profile with human acetylcholinesterase: docking and electronic structure.

机构信息

Computational Chemistry Laboratory, Institute of Chemistry, University of Brasilia, Brasilia, DF, 70910-900, Brazil.

出版信息

J Mol Model. 2022 Aug 10;28(9):252. doi: 10.1007/s00894-022-05252-2.

DOI:10.1007/s00894-022-05252-2
PMID:35947248
Abstract

Alzheimer disease (AD) is a neurodegenerative process, one of the most common and incident dementia in the population over 60 years. AD manifests the presence of complex biochemical processes involved in neuronal degeneration, such as the formation of senile plaques containing amyloid-β peptides, the development of intracellular neurofibrillary tangles, and the suppression of the acetylcholine neurotransmitter. In this way, we performed a set of theoretical tests of tacrine ligand and acetylcholine neurotransmitter against the human acetylcholinesterase enzyme. Molecular docking was used to understand the most important interactions of these molecules with the enzyme. Computational chemistry calculation was carried out using MP2, DFT, and semi-empirical methods, starting from molecular docking structures. We have also performed studies regarding the non-covalent interactions, electron localization function, molecular electrostatic potential and explicit water molecule influence. For Trp86 residue, we show two main interactions in accordance to the results of the literature for TcAChE. First, intermolecular interactions of the cation-π and sigma-π type were found. Second, close stacking interactions were stablished between THA+ and Trp86 residue on one side and with Tyr337 residue on the other side.

摘要

阿尔茨海默病(AD)是一种神经退行性过程,是 60 岁以上人群中最常见和最常见的痴呆症之一。AD 表现为涉及神经元变性的复杂生化过程的存在,例如含有淀粉样β肽的老年斑的形成、细胞内神经原纤维缠结的发展以及乙酰胆碱递质的抑制。 为此,我们对他克林配体和乙酰胆碱递质对人乙酰胆碱酯酶进行了一系列理论测试。 分子对接用于了解这些分子与酶的最重要相互作用。 使用 MP2、DFT 和半经验方法从分子对接结构开始进行计算化学计算。 我们还进行了关于非共价相互作用、电子定域函数、分子静电势和显式水分子影响的研究。 对于 Trp86 残基,根据 TcAChE 的文献结果,我们显示了两种主要相互作用。 首先,发现了阳离子-π 和 sigma-π 类型的分子间相互作用。 其次,THA+ 与 Trp86 残基一侧以及 Tyr337 残基另一侧之间建立了紧密的堆积相互作用。

相似文献

1
In silico study of tacrine and acetylcholine binding profile with human acetylcholinesterase: docking and electronic structure.他克林与人乙酰胆碱酯酶结合特性的计算研究:对接和电子结构。
J Mol Model. 2022 Aug 10;28(9):252. doi: 10.1007/s00894-022-05252-2.
2
Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase.人源乙酰胆碱酯酶和丁酰胆碱酯酶与 huprine W 和他克林复合物的晶体结构:针对乙酰胆碱酯酶和丁酰胆碱酯酶的阿尔茨海默病治疗药物的特异性要素。
Biochem J. 2013 Aug 1;453(3):393-9. doi: 10.1042/BJ20130013.
3
Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.他克林衍生物作为阿尔茨海默病潜在乙酰胆碱酯酶(AChE)抑制剂的联合3D-QSAR、分子对接和分子动力学研究
J Mol Model. 2015 Oct;21(10):277. doi: 10.1007/s00894-015-2797-8. Epub 2015 Oct 5.
4
Sub-pocket-focused designing of tacrine derivatives as potential acetylcholinesterase inhibitors.他克林衍生物作为潜在乙酰胆碱酯酶抑制剂的亚口袋聚焦设计
Comput Biol Med. 2023 Mar;155:106666. doi: 10.1016/j.compbiomed.2023.106666. Epub 2023 Feb 11.
5
Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor.靶向乙酰胆碱酯酶和α7 烟碱型乙酰胆碱受体的多功能配体的功能特征。
Biochem Pharmacol. 2020 Jul;177:114010. doi: 10.1016/j.bcp.2020.114010. Epub 2020 Apr 30.
6
Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment.他克林衍生物作为阿尔茨海默病治疗中乙酰胆碱酯酶抑制剂的三维定量构效关系及药效团模型
Med Chem. 2020;16(2):155-168. doi: 10.2174/1573406415666190513100646.
7
Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.乙酰胆碱酯酶抑制剂的分子对接和受体特异性 3D-QSAR 研究。
Mol Divers. 2012 Nov;16(4):803-23. doi: 10.1007/s11030-012-9394-x. Epub 2012 Sep 21.
8
Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry.乙酰胆碱酯酶抑制剂的计算研究:从生物化学到化学。
Mini Rev Med Chem. 2020;20(14):1403-1435. doi: 10.2174/1389557520666191224144346.
9
Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer's disease.计算方法提出一种新的多靶标导向配体作为治疗阿尔茨海默病的潜在药物。
J Biomol Struct Dyn. 2019 Nov;37(18):4825-4839. doi: 10.1080/07391102.2018.1564701. Epub 2019 Jan 28.
10
Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.设计用于抑制人类乙酰胆碱酯酶的金属基多奈哌齐类似物,用于治疗阿尔茨海默病。
PLoS One. 2019 Feb 20;14(2):e0211935. doi: 10.1371/journal.pone.0211935. eCollection 2019.

引用本文的文献

1
Docking heparan sulfate-based ligands as a promising inhibitor for SARS-CoV-2.对接基于硫酸乙酰肝素的配体作为一种有前景的新型冠状病毒抑制剂。
J Mol Model. 2024 Dec 12;31(1):19. doi: 10.1007/s00894-024-06236-0.
2
In Silico Molecular Modeling of Four New Afatinib Derived Molecules Targeting the Inhibition of the Mutated Form of BCR-ABL T315I.基于计算机的四种新型阿法替尼衍生物分子模拟靶向抑制突变型 BCR-ABL T315I
Molecules. 2024 Sep 8;29(17):4254. doi: 10.3390/molecules29174254.
3
A Mouse Model of Sporadic Alzheimer's Disease with Elements of Major Depression.

本文引用的文献

1
Binding Mechanism between Acetylcholinesterase and Drugs Pazopanib and Lapatinib: Biochemical and Biophysical Studies.乙酰胆碱酯酶与药物帕唑帕尼和拉帕替尼结合机制的生化和生物物理研究。
ACS Chem Neurosci. 2021 Dec 15;12(24):4500-4511. doi: 10.1021/acschemneuro.1c00521. Epub 2021 Nov 22.
2
Deciphering the AChE-binding mechanism with multifunctional tricyclic coumarin anti-Alzheimer's agents using biophysical and bioinformatics approaches and evaluation of their modulating effect on Amyloidogenic peptide assembly.利用生物物理和生物信息学方法解析多功能三环香豆素抗阿尔茨海默病药物与乙酰胆碱酯酶的结合机制,并评估其对淀粉样肽组装的调节作用。
Int J Biol Macromol. 2021 Dec 15;193(Pt B):1409-1420. doi: 10.1016/j.ijbiomac.2021.10.204. Epub 2021 Nov 2.
3
一种具有重度抑郁特征的散发性阿尔茨海默病小鼠模型。
Mol Neurobiol. 2025 Feb;62(2):1337-1358. doi: 10.1007/s12035-024-04346-7. Epub 2024 Jul 9.
4
Comparative analysis of the reactivity of anthocyanidins, leucoanthocyanidins, and flavonols using a quantum chemistry approach.使用量子化学方法对花色苷、无色花色苷和类黄酮的反应性进行比较分析。
J Mol Model. 2023 Mar 11;29(4):93. doi: 10.1007/s00894-023-05468-w.
Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.深入了解化学工具设计的机制,以控制阿尔茨海默病中的多种致病特征。
Acc Chem Res. 2021 Oct 19;54(20):3930-3940. doi: 10.1021/acs.accounts.1c00457. Epub 2021 Oct 4.
4
Investigation on the interaction behavior of afatinib, dasatinib, and imatinib docked to the BCR-ABL protein.研究阿法替尼、达沙替尼和伊马替尼与 BCR-ABL 蛋白对接的相互作用行为。
J Mol Model. 2021 Oct 1;27(10):309. doi: 10.1007/s00894-021-04925-8.
5
M1 muscarinic acetylcholine receptor-mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons.M1 毒蕈碱型乙酰胆碱受体介导的纹状体中间神经元上 GABA 释放对胆碱能中间神经元的抑制作用。
Eur J Neurosci. 2021 Feb;53(3):796-813. doi: 10.1111/ejn.15074. Epub 2020 Dec 20.
6
Drug repurposing for Alzheimer's disease: and investigation of FDA-approved drugs as acetylcholinesterase inhibitors.用于阿尔茨海默病的药物重新利用:以及对美国食品药品监督管理局批准的作为乙酰胆碱酯酶抑制剂的药物的研究。
J Biomol Struct Dyn. 2022 Apr;40(7):2878-2892. doi: 10.1080/07391102.2020.1844054. Epub 2020 Nov 10.
7
A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies.人乙酰胆碱酯酶的一种新晶体形式,用于探索室温晶体学研究。
Chem Biol Interact. 2019 Aug 25;309:108698. doi: 10.1016/j.cbi.2019.06.011. Epub 2019 Jun 7.
8
Analysis of lowest energy transitions at TD-DFT of pyrene in vacuum and solvent.芘在真空和溶剂中的TD-DFT最低能量跃迁分析。
J Mol Model. 2019 Jun 7;25(7):183. doi: 10.1007/s00894-019-4065-9.
9
Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics.基于他克林的高效乙酰胆碱酯酶选择性和可逆同型二聚体试剂用于治疗诊断学。
Mol Pharm. 2019 Jun 3;16(6):2296-2308. doi: 10.1021/acs.molpharmaceut.8b01058. Epub 2019 May 15.
10
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy.天然存在的乙酰胆碱酯酶抑制剂及其在阿尔茨海默病治疗中的潜在用途。
Front Pharmacol. 2018 Oct 18;9:1192. doi: 10.3389/fphar.2018.01192. eCollection 2018.